Skip to search boxSkip to navigationSkip to main content

Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis

  • Nan Bi
    ,
  • Kerby Shedden
    ,
  • Xiangpeng Zheng
    ,
  • Feng Ming Kong(corresponding author)
*Corresponding author for this work
  • Chinese Academy of Medical Sciences
    ,
  • University of Michigan, Ann Arbor
    ,
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Purpose To performed a systematic review and pooled analysis to compare clinical outcomes of stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA) for the treatment of medically inoperable stage I non-small cell lung cancer. Methods and Materials A comprehensive literature search for published trials from 2001 to 2012 was undertaken. Pooled analyses were performed to obtain overall survival (OS) and local tumor control rates (LCRs) and adverse events. Regression analysis was conducted considering each study's proportions of stage IA and age. Results Thirty-one studies on SBRT (2767 patients) and 13 studies on RFA (328 patients) were eligible. The LCR (95% confidence interval) at 1, 2, 3, and 5 years for RFA was 77% (70%-85%), 48% (37%-58%), 55% (47%-62%), and 42% (30%-54%) respectively, which was significantly lower than that for SBRT: 97% (96%-98%), 92% (91%-94%), 88% (86%-90%), and 86% (85%-88%) (P<.001). These differences remained significant after correcting for stage IA and age (P<.001 at 1 year, 2 years, and 3 years; P=.04 at 5 years). The effect of RFA was not different from that of SBRT on OS (P>.05). The most frequent complication of RFA was pneumothorax, occurring in 31% of patients, whereas that for SBRT (grade ≥3) was radiation pneumonitis, occurring in 2% of patients. Conclusions Compared with RFA, SBRT seems to have a higher LCR but similar OS. More studies with larger sample sizes are warranted to validate such findings.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1378-1390 (13 pages)

Journal (Volume, Issue Number)

International Journal of Radiation Oncology Biology Physics (Volume 95, Issue 5)

Publication milestones

  • Published - 08/01/2016

Publication status

Published - 08/01/2016

ISSN

0360-3016

Publication IDs

  • Scopus: 84990833616
  • PubMed: 27479723

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
7.00
SciVal
Author count
4
SciVal
citations
43
SciVal
Paper percentile
95
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
98
Citation count
109

Funding Details

This work was funded in part by National Institutes of Health grants R21CA127057 and R01 CA142840 .
FundersFunding numbers
NIH
R01 CA142840
NCI
R21CA127057